Research Square
Blood markers linked to risk in cardiovascular-kidney-metabolic stage 2
Six-year risk of cardiovascular disease or death was 15.9% with lower levels of a heart-strain marker versus 44.0% with higher levels.Six-year risk of cardiovascular disease or death was 15.9% with lower levels of a heart-strain marker versus 44.0% with higher levels.
Preprint: cohort · 6,205 peopleCardiovascular disease
Who was studied6,205 older adults with CKM stage 2, against participants with higher NT-proBNP
What changedOver six-year follow-up, cardiovascular disease or death risk was 15.9% with lower NT-proBNP versus 44.0% with higher levels
The catchCardiovascular disease was identified from self-reported physician diagnoses, leaving events vulnerable to reporting errors